person

Elvira S.

Country
Italy
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 39 partner sites.

Specializations

Gynecologic Oncology

This investigator specializes in the treatment of low-grade serous epithelial ovarian cancer, with particular focus on hormone receptor-positive disease variants. Their research encompasses advanced stages of ovarian malignancies, including those affecting the fallopian tubes and peritoneum.

  • Ovarian Cancer Treatment
  • Hormone Receptor-Positive Cancers
  • Advanced Stage Malignancies

The investigator's expertise extends to endocrine therapy approaches in gynecologic cancers, specifically examining alternatives to conventional chemotherapy treatments.

Endocrine Therapeutics

Their work centers on developing hormone-based treatment strategies for gynecologic cancers, particularly focusing on cases where tumors express estrogen and progesterone receptors.

  • Hormonal Therapy Development
  • Receptor-Targeted Treatments
  • Alternative Treatment Approaches

The investigator explores innovative therapeutic options for patients with specific hormone receptor profiles, aiming to advance personalized treatment strategies.

Clinical Outcomes

The investigator focuses on evaluating progression-free survival in advanced ovarian cancer patients, particularly examining the effectiveness of targeted therapies compared to standard treatments.

  • Treatment Response Assessment
  • Survival Outcomes Research
  • Comparative Treatment Studies

Their research encompasses comprehensive evaluation of treatment outcomes in FIGO stage III-IV gynecologic cancers.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.